Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bausch Health Companies Inc.BHC · Entity 4363 | SVP, Controller & CAO | February 28, 2025 | March 03, 2025 |
| Solstice Advanced Materials Inc.SOLS · Entity 3540 | Chief Accounting Officer | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bausch Health Companies Inc.
Report date February 28, 2025 · Filed March 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, No Par ValueSEC Table I · non-derivative | Direct | 192,268 |
Ending reported balance
After 2025-02-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-02-28 · Tax withholding · Disposed 2,865 · Balance 197,364 F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Row 2 · 2025-02-28 · Tax withholding · Disposed 5,096 · Balance 192,268 F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. |
Filing footnotes · ownership attribution and instrument terms
F1: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
Solstice Advanced Materials Inc.
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,569 |
Reported balance
After 2026-09-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-10 · Grant · Acquired 4 · Balance 3,569 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs. F3: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 15,992 |
Reported balance
After 2026-09-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-10 · Grant · Acquired 19 · Balance 15,992 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs. F4: The RSUs vest 8,583 on June 16, 2026, 8,579 on June 16, 2027 and 7,363 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. |
| Common StockSEC Table I · non-derivative | Direct | 5,355 |
Reported balance
Holding disclosure · report date 2026-09-10 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,355 |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number.
F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs.
F3: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment.
F4: The RSUs vest 8,583 on June 16, 2026, 8,579 on June 16, 2027 and 7,363 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BED BATH & BEYOND INC
Report date May 10, 2022 · Filed July 15, 2022
Section 16 reporting ended · disclosed 2022-07-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Units (RSUs)SEC Table II · derivative / convertible security | Direct | 13,278 |
Reported balance
After 2022-05-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-10 · Grant · Acquired 13,278 · Balance 13,278 F1: Each restricted stock unit ("RSU") represents a contingent right to receive the cash value of one share of Issuer common stock upon vesting. F2: Represents a grant of RSUs awarded to the Reporting Person under the Issuer's 2018 Incentive Compensation Plan. 1/3 of the RSUs will vest on May 10th of each of 2023, 2024, and 2025, in each case, subject to the terms, conditions and restrictions of the award agreement governing the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive the cash value of one share of Issuer common stock upon vesting.
F2: Represents a grant of RSUs awarded to the Reporting Person under the Issuer's 2018 Incentive Compensation Plan. 1/3 of the RSUs will vest on May 10th of each of 2023, 2024, and 2025, in each case, subject to the terms, conditions and restrictions of the award agreement governing the grant.
TIFFANY & CO
Report date July 20, 2017 · Filed July 28, 2017
Section 16 reporting ended · disclosed 2017-07-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock $.01 ParSEC Table I · non-derivative | Direct | 4,173 |
Reported balance
Holding disclosure · report date 2017-07-20 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,173 F1: 3,198 shares in the total are unvested restricted stock units. |
| Common Stock $.01 ParSEC Table I · non-derivative | IndirectBY 401K | 277 |
Reported balance
Holding disclosure · report date 2017-07-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 277 |
| Common Stock $.01 ParSEC Table I · non-derivative | IndirectBY ESOP | 41 |
Reported balance
Holding disclosure · report date 2017-07-20 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 41 |
Filing footnotes · ownership attribution and instrument terms
F1: 3,198 shares in the total are unvested restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 14, 2026 21:29 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | GrantRestricted Stock Units · Derivative | 19 | $0.00 | $0.00 |
DisclosureSEC source: 0001578223-26-000008 · wk-form4_1789421347.xml · derivative · entry 3 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,992 Underlying: Common Stock · 19 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs. F4 · derivative.exercise_date: The RSUs vest 8,583 on June 16, 2026, 8,579 on June 16, 2027 and 7,363 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. F4 · derivative.expiration_date: The RSUs vest 8,583 on June 16, 2026, 8,579 on June 16, 2027 and 7,363 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 21:29 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | GrantRestricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001578223-26-000008 · wk-form4_1789421347.xml · derivative · entry 2 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,569 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs. F3 · derivative.exercise_date: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. F3 · derivative.expiration_date: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:02 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | Exercise / conversionRestricted Stock Units · Derivative | 8,600 | $0.00 | $0.00 |
DisclosureSEC source: 0002064953-26-000078 · wk-form4_1781816519.xml · derivative · entry 3 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,973 Underlying: Common Stock · 8,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. F4 · derivative.exercise_date: The RSUs vest 8,583 on June 16, 2026, 8,579 on June 16, 2027 and 7,363 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. F4 · derivative.expiration_date: The RSUs vest 8,583 on June 16, 2026, 8,579 on June 16, 2027 and 7,363 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:02 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | Tax withholdingCommon Stock | 3,244 | $85.79 | $278,302.76 |
DisclosureSEC source: 0002064953-26-000078 · wk-form4_1781816519.xml · nonDerivative · entry 2 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,355 F3 · shares: Represents shares withheld for taxes upon vesting of RSUs. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:02 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | Exercise / conversionCommon Stock | 8,599 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002064953-26-000078 · wk-form4_1781816519.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,599 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the settlement of fractional shares in cash. F2 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:01 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | GrantRestricted Stock Units · Derivative | 23 | $0.00 | $0.00 |
DisclosureSEC source: 0002064953-26-000063 · wk-form4_1781298095.xml · derivative · entry 2 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,573 Underlying: Common Stock · 23 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs. F4 · derivative.exercise_date: The RSUs will vest 8,584 on June 16, 2026, 8,584 on June 16, 2027 and 7,357 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. F4 · derivative.expiration_date: The RSUs will vest 8,584 on June 16, 2026, 8,584 on June 16, 2027 and 7,357 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 21:01 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0002064953-26-000063 · wk-form4_1781298095.xml · derivative · entry 1 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,565 Underlying: Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. Fractional amounts have been rounded to the nearest whole number. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs. F3 · derivative.exercise_date: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. F3 · derivative.expiration_date: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | GrantRestricted Stock Units · Derivative | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0001578223-26-000003 · wk-form4_1773346924.xml · derivative · entry 2 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,550 Underlying: Common Stock · 25 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs. F4 · derivative.exercise_date: The RSUs will vest 8,584 on June 16, 2026, 8,584 on June 16, 2027 and 7,357 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. F4 · derivative.expiration_date: The RSUs will vest 8,584 on June 16, 2026, 8,584 on June 16, 2027 and 7,357 on June 16, 2028 (in each case, not including dividend equivalent rights), subject to continued employment. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:22 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | GrantRestricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0001578223-26-000003 · wk-form4_1773346924.xml · derivative · entry 1 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,562 Underlying: Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. (the "Issuer") common stock. F2 · kind: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in RSUs that vest at the same times as the underlying RSUs. F3 · derivative.exercise_date: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. F3 · derivative.expiration_date: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 22:32 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | GrantRestricted Stock Units · Derivative | 3,558 | $0.00 | $0.00 |
DisclosureSEC source: 0002064953-26-000014 · wk-form4_1772058743.xml · derivative · entry 1 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,558 Underlying: Common Stock · 3,558 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Materials Inc. common stock. F2 · derivative.exercise_date: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. F2 · derivative.expiration_date: The RSUs will vest 33% on each of February 24, 2027 and February 24, 2028, and 34% on February 24, 2029, subject to continued employment. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:37 UTC | Solstice Advanced Materials Inc. SOLS · Entity 3540 | GrantRestricted Stock Units · Derivative | 24,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-048314 · wk-form4_1762205826.xml · derivative · entry 1 Barresi John S · CIK 0001578223 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,525 Underlying: Common Stock · 24,525 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Solstice Advanced Material Inc. (the "Issuer") common stock. F2 · derivative.exercise_date: Represents equity awards originally granted by Honeywell International Inc. ("Honeywell") that have been converted into equity awards of the Issuer in connection with the spin-off of the Issuer from Honeywell. The RSUs will vest 8,584 on June 16, 2026, 8,584 on June 16, 2027 and 7,357 on June 16, 2028, subject to continued employment. F2 · derivative.expiration_date: Represents equity awards originally granted by Honeywell International Inc. ("Honeywell") that have been converted into equity awards of the Issuer in connection with the spin-off of the Issuer from Honeywell. The RSUs will vest 8,584 on June 16, 2026, 8,584 on June 16, 2027 and 7,357 on June 16, 2028, subject to continued employment. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:08 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 5,096 | $7.44 | $37,914.24 |
DisclosureSEC source: 0001127602-25-007483 · form4.xml · nonDerivative · entry 2 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,268 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 21:08 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 2,865 | $7.44 | $21,315.60 |
DisclosureSEC source: 0001127602-25-007483 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 197,364 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:45 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 49,823 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-007291 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,229 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 05, 2024 Filed Sep 9, 2024 20:37 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 3,982 | $6.19 | $24,648.58 |
DisclosureSEC source: 0001127602-24-023662 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,406 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 20:34 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 49,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020740 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,388 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 20:16 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,930 | $6.73 | $12,988.90 |
DisclosureSEC source: 0001127602-24-019126 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,134 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:24 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 3,188 | $9.89 | $31,529.32 |
DisclosureSEC source: 0001127602-24-008129 · form4.xml · nonDerivative · entry 2 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,064 F2 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:24 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 39,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-008129 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,252 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-half on each of the first two anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares"). Read SEC document |
| February 29, 2024 Filed Jun 6, 2024 21:18 UTC Amendment | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 39,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-018086 · form4a.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,252 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 05, 2023 Filed Sep 6, 2023 20:31 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 3,982 | $8.35 | $33,249.70 |
DisclosureSEC source: 0001127602-23-023784 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,126 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| June 20, 2023 Filed Jun 21, 2023 20:10 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | Tax withholdingCommon Shares, No Par Value | 1,929 | $7.40 | $14,274.60 |
DisclosureSEC source: 0001127602-23-019149 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,108 F1 · shares: This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantNon-Qualified Stock Options (right to purchase) · Derivative | 21,812 | $0.00 Strike: $9.25 | $0.00 |
DisclosureSEC source: 0001127602-23-009094 · form4.xml · derivative · entry 2 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,812 Underlying: Common Shares, No Par Value · 21,812 shares Expires 2033-03-02 F2 · derivative.exercise_date: The options vest in equal installments on each of the first three anniversaries of the date of grant. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:47 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 25,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009094 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,037 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| September 05, 2022 Filed Sep 8, 2022 00:33 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 34,873 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022166 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,771 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| June 20, 2022 Filed Jun 22, 2022 22:30 UTC | Bausch Health Companies Inc. BHC · Entity 4363 | GrantCommon Shares, No Par Value | 16,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017993 · form4.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,898 F1 · shares: Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. Read SEC document |
| May 10, 2022 Filed Jul 15, 2022 16:52 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | GrantRestricted Stock Units (RSUs) · Derivative | 13,278 | $0.00 | $0.00 |
DisclosureSEC source: 0000886158-22-000126 · wf-form4_165791835519911.xml · derivative · entry 1 Barresi John S · CIK 0001578223 · FORMER CHIEF ACCOUNTING OFC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,278 Underlying: Common Stock · 13,278 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive the cash value of one share of Issuer common stock upon vesting. F2 · derivative.exercise_date: Represents a grant of RSUs awarded to the Reporting Person under the Issuer's 2018 Incentive Compensation Plan. 1/3 of the RSUs will vest on May 10th of each of 2023, 2024, and 2025, in each case, subject to the terms, conditions and restrictions of the award agreement governing the grant. F2 · derivative.expiration_date: Represents a grant of RSUs awarded to the Reporting Person under the Issuer's 2018 Incentive Compensation Plan. 1/3 of the RSUs will vest on May 10th of each of 2023, 2024, and 2025, in each case, subject to the terms, conditions and restrictions of the award agreement governing the grant. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 19:30 UTC | BED BATH & BEYOND INC BBBY · Entity 117013 | GrantCommon Stock, $.01 par value per share | 7,486 | $0.00 | $0.00 |
DisclosureSEC source: 0001387131-21-006531 · barresi-form4_061121.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,486 F1 · shares: Represents a grant of restricted stock units ("RSUs") awarded to the Reporting Person under the Company's 2012 Incentive Compensation Plan. 2,495 of the RSUs will vest on June 10, 2022, 2,495 of the RSUs will vest on June 10, 2023 and 2,496 of the RSUs will vest on June 10, 2024, in each case, subject to the terms, conditions and restrictions of the award agreement governing the grant. Read SEC document |
| July 10, 2017 Filed Jul 12, 2017 15:59 UTC | TIFFANY & CO TIF · Entity 143953 | GrantDividend Equivalent Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-17-000176 · wf-form4_149988955089098.xml · derivative · entry 4 Barresi John S · CIK 0001578223 · VP-PRINC. ACCTG. OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8 Underlying: Common Stock $.01 Par · 4 shares Expires not disclosed F2 · derivative.exercise_price: Represents dividend equivalent units accrued on July 10, 2017 in respect of restricted stock units granted to the reporting person on March 15, 2017 pursuant to the Tiffany & Co. 2014 Employee Incentive Plan, which complies with Rule 16b-3. The dividend equivalent units convert to the issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The dividend equivalent units will vest proportionately with the underlying restricted stock units to which they relate. The dividend equivalent units credited in respect of the restricted stock units granted on March 15, 2017 will vest in four equal annual installments on March 15, 2018, 2019, 2020 and 2021. F3 · derivative.expiration_date: The dividend equivalent units will vest proportionately with the underlying restricted stock units to which they relate. The dividend equivalent units credited in respect of the restricted stock units granted on March 15, 2017 will vest in four equal annual installments on March 15, 2018, 2019, 2020 and 2021. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 16:36 UTC | TIFFANY & CO TIF · Entity 143953 | GrantDividend Equivalent Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-17-000118 · wf-form4_149202940348716.xml · derivative · entry 4 Barresi John S · CIK 0001578223 · VP-PRINC. ACCTG. OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4 Underlying: Common Stock $.01 Par · 4 shares Expires not disclosed F2 · derivative.exercise_price: Represents dividend equivalent units accrued on April 10, 2017 in respect of restricted stock units granted to the reporting person on March 15, 2017 pursuant to the Tiffany & Co. 2014 Employee Incentive Plan, which complies with Rule 16b-3. The dividend equivalent units convert to the issuer's common stock on a one-for-one basis. F3 · derivative.exercise_date: The dividend equivalent units will vest proportionately with the underlying restricted stock units to which they relate. The dividend equivalent units credited in respect of the restricted stock units granted on March 15, 2017, will vest in four equal annual installments on March 15, 2018, 2019, 2020 and 2021. F3 · derivative.expiration_date: The dividend equivalent units will vest proportionately with the underlying restricted stock units to which they relate. The dividend equivalent units credited in respect of the restricted stock units granted on March 15, 2017, will vest in four equal annual installments on March 15, 2018, 2019, 2020 and 2021. Read SEC document |
| March 21, 2017 Filed Mar 22, 2017 16:03 UTC | TIFFANY & CO TIF · Entity 143953 | SaleCommon Stock $.01 Par | 1,027 | $94.38 | $96,925.80 |
DisclosureSEC source: 0000098246-17-000070 · wf-form4_149021298125277.xml · nonDerivative · entry 2 Barresi John S · CIK 0001578223 · VP-PRINC. ACCTG. OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,173 F2 · balance_after: 3,198 shares in the total are unvested restricted stock units. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 16:03 UTC | TIFFANY & CO TIF · Entity 143953 | Tax withholdingCommon Stock $.01 Par | 358 | $93.93 | $33,625.15 |
DisclosureSEC source: 0000098246-17-000070 · wf-form4_149021298125277.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · VP-PRINC. ACCTG. OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,200 F1 · shares: Shares withheld to cover taxes on vested restricted stock units pursuant to issuer's default equity vesting procedures. F2 · balance_after: 3,198 shares in the total are unvested restricted stock units. Read SEC document |
| March 16, 2017 Filed Mar 17, 2017 16:17 UTC | TIFFANY & CO TIF · Entity 143953 | Tax withholdingCommon Stock $.01 Par | 166 | $90.19 | $14,970.71 |
DisclosureSEC source: 0000098246-17-000062 · wf-form4_148978182349852.xml · nonDerivative · entry 2 Barresi John S · CIK 0001578223 · VP-PRINC. ACCTG. OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,558 F4 · shares: Shares withheld to cover taxes on vested restricted stock units pursuant to issuer's default equity vesting procedures. F5 · balance_after: 4,150 shares in the total are unvested restricted stock units. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 16:17 UTC | TIFFANY & CO TIF · Entity 143953 | GrantCommon Stock $.01 Par | 1,108 | $0.00 | $0.00 |
DisclosureSEC source: 0000098246-17-000062 · wf-form4_148978182349852.xml · nonDerivative · entry 1 Barresi John S · CIK 0001578223 · VP-PRINC. ACCTG. OFF 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,724 F1 · shares: Represents a grant of unvested restricted stock units. These restricted stock units vest in four equal annual installments on March 15, 2018, 2019, 2020 and 2021. F2 · price: Given for no consideration. F3 · balance_after: 4,542 shares in the total are unvested restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.